Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States.

ABSTRACT:

Background

Metastatic prostate cancer (MPC) includes metastases detected at diagnosis (de novo) and those occurring after diagnosis with early-stage disease (recurrent). Cancer registries collect data only on de novo MPC, providing a partial picture of the burden of MPC. We use cancer registry data to estimate the number of men living with MPC in the United States including both de novo and recurrent cases.

Methods

We apply a back-calculation method to estimate MPC incidence and prevalence from U.S. prostate cancer mortality and de novo MPC relative survival for cases diagnosed between 2000 and 2017 in 18 Surveillance, Epidemiology, and End Results registries. We hold overall prostate cancer mortality and MPC survival constant for future prevalence projections.

Results

SUBMITTER: Devasia TP 

PROVIDER: S-EPMC10159917 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature